TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
OVID

Ovid Therapeutics Inc

Healthcare · Biotechnology

2.50$ -0.4% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Ovid Therapeutics Inc (OVID)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.7% of the shares are freely tradable; institutional investors hold 73.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 73.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 83.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 11.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 189Mio.

Largest Shareholders

Institutions

Institutions OVID
Name Stake (%) Shares Change (%) Date
Jupiter Topco LLC 10.62 20,741,234 +0.0 06/30/2026
Eventide Asset Management, LLC 6.05 11,812,241 +19.1 06/30/2026
BlackRock Inc 5.54 10,823,480 +605.9 06/30/2026
RA Capital Management, LLC 5.38 10,500,968 -2.0 06/30/2026
Affinity Asset Advisors, LLC 5.19 10,144,562 -4.6 06/30/2026
State Street Corp 4.05 7,900,765 +1,418.6 06/30/2026
Vanguard Capital Management, LLC 3.97 7,760,114 +47.6 06/30/2026
ADAR1 Capital Management LLC 3.80 7,417,479 +63.2 06/30/2026
Balyasny Asset Management LLC 3.44 6,719,076 +21.4 06/30/2026

Funds

Funds OVID
Name Stake (%) Shares Change (%) Date
Eventide Healthcare & Life Sciences I 6.05 11,812,241 +19.1 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?